Tag: Cancer: Breast
Efficacy of Durvalumab for Early-Stage TNBC Examined by Race
In Phase I/II trial of durvalumab with neoadjuvant chemo, pathological complete response rates similar for Black, non-Black patients
Diet High in n-3-PUFAs Linked to Lower Breast Cancer Risk
Higher intake of marine n-3 PUFAs and total n-3 PUFAs associated with lower risk for breast cancer, especially for premenopausal women
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer
HER2-low is a new classification for a subset of HER2-negative breast cancer
Disparities Examined in Perceptions of Breast Reconstruction Outcomes
Nearly 40 percent of women have perceptions of breast reconstruction that are better or worse than those of third-party observers
Hormone Therapy Not Tied to Breast Cancer Recurrence, Mortality
No increased risk seen for women using either vaginal estrogen therapy or menopausal hormone therapy after diagnosis
Pembrolizumab Ups Survival in Advanced Triple-Negative Breast Cancer
Overall survival longer with addition of pembrolizumab to chemo in tumors expressing PD-L1 with combined positive score of 10 or more
Knowing Maternal BRCA Carrier Status Does Not Harm Child QOL
Adolescent and young adult children of BRCA+ mothers more concerned about cancer, had stronger beliefs about genetic risk
Diagnostic Mammogram Performance Varies by Race/Ethnicity
Invasive cancer detection rates, positive predictive values highest for non-Hispanic Whites, lowest for Hispanics
Hormone Therapy-Related Hot Flashes Tied to Worse Breast Cancer Outcomes
Findings for chemotherapy-free patients with breast cancer
Exercise Improves Global Longitudinal Strain in Breast Cancer Survivors
Significantly lower risks of abnormal GLS for moderately active and active survivors versus those who are inactive
